Lung imaging patterns in connective tissue disease-associated interstitial lung disease impact prognosis and immunosuppression response

Rheumatology (Oxford). 2024 Oct 1;63(10):2734-2740. doi: 10.1093/rheumatology/keae076.

Abstract

Objectives: Interstitial lung disease (ILD) in CTDs has highly variable morphology. We aimed to identify imaging features and their impact on ILD progression, mortality, and immunosuppression response.

Methods: Patients with CTD-ILD had high-resolution chest CT (HRCT) reviewed by expert radiologists blinded to clinical data for overall imaging pattern [usual interstitial pneumonia (UIP); non-specific interstitial pneumonia (NSIP); organizing pneumonia (OP); fibrotic hypersensitivity pneumonitis (fHP); and other]. Transplant-free survival and change in percent-predicted forced vital capacity (FVC) were compared using Cox and linear mixed-effects models adjusted for age, sex, smoking, and baseline FVC. FVC decline after immunosuppression was compared with pre-treatment.

Results: Among 645 CTD-ILD patients, the most frequent CTDs were SSc (n = 215), RA (n = 127), and inflammatory myopathies (n = 100). NSIP was the most common pattern (54%), followed by UIP (20%), fHP (9%), and OP (5%). Compared with the case for patients with UIP, FVC decline was slower in patients with NSIP (by 1.1%/year, 95% CI 0.2, 1.9) or OP (by 3.5%/year, 95% CI 2.0, 4.9), and mortality was lower in patients with NSIP [hazard ratio (HR) 0.65, 95% CI 0.45, 0.93] or OP (HR 0.18, 95% CI 0.05, 0.57), but higher in fHP (HR 1.58, 95% CI 1.01, 2.40). The extent of fibrosis also predicted FVC decline and mortality. After immunosuppression, FVC decline was slower compared with pre-treatment in NSIP (by 2.1%/year, 95% CI 1.4, 2.8), with no change for UIP or fHP.

Conclusion: Multiple radiologic patterns are possible in CTD-ILD, including a fHP pattern. NSIP and OP were associated with better outcomes and response to immunosuppression, while fHP had worse survival compared with UIP.

Keywords: connective tissue disease; interstitial lung disease; prognosis; radiologic patterns.

MeSH terms

  • Adult
  • Aged
  • Connective Tissue Diseases* / complications
  • Connective Tissue Diseases* / diagnostic imaging
  • Disease Progression
  • Female
  • Humans
  • Immunosuppression Therapy
  • Immunosuppressive Agents / therapeutic use
  • Lung / diagnostic imaging
  • Lung / physiopathology
  • Lung Diseases, Interstitial* / diagnostic imaging
  • Lung Diseases, Interstitial* / drug therapy
  • Lung Diseases, Interstitial* / etiology
  • Lung Diseases, Interstitial* / mortality
  • Lung Diseases, Interstitial* / physiopathology
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Tomography, X-Ray Computed*
  • Vital Capacity

Substances

  • Immunosuppressive Agents